Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin
International Journal of Molecular Sciences · 15.08.2023 · 24 (16) · 12816
DOI: 10.3390/ijms241612816 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.08.2023. Verfasst von Tak Gyeom Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea. Hauptthemen laut MEDLINE: TNF-Related Apoptosis-Inducing Ligand, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Keimyung University, Korean Government (MSIP).
Abstract (Originalsprache)
Ubiquitin-specific protease 2 (USP2) is a deubiquitinase belonging to the USPs subfamily. USP2 has been known to display various biological effects including tumorigenesis and inflammation. Therefore, we aimed to examine the sensitization effect of USP2 in TRAIL-mediated apoptosis. The pharmacological inhibitor (ML364) and siRNA targeting USP2 enhanced TNF-related apoptosis-inducing ligand (TRAIL)-induced cancer cell death, but not normal cells. Mechanistically, USP2 interacted with survivin, and ML364 degraded survivin protein expression by increasing the ubiquitination of survivin. Overexpression of survivin or USP2 significantly prevented apoptosis through cotreatment with ML364 and TRAIL, whereas a knockdown of USP2 increased sensitivity to TRAIL. Taken together, our data suggested that ML364 ubiquitylates and degrades survivin, thereby increasing the reactivity to TRAIL-mediated apoptosis in cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
- Research Institute of Biomedical Engineering and Department of Cell Biology, School of Medicine, Catholic University of Daegu, Daegu 42472, Republic of Korea.
- Center for Forensic Pharmaceutical Science, Keimyung University, Daegu 42601, Republic of Korea.
ORCID-Profile: Shin Kim, Young-Chae Chang, Taeg Kyu Kwon
Förderung
- Keimyung University
- Korean Government (MSIP)
Zitieren
APA
Lee, T. G., Woo, S. M., Seo, S. U., Kim, S., Park, J. W., Chang, Y. C., & Kwon, T. K. (2023). Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin. International Journal of Molecular Sciences, 24(16), 12816. https://doi.org/10.3390/ijms241612816
Vancouver
Lee TG, Woo SM, Seo SU, Kim S, Park JW, Chang YC, et al. Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin. International Journal of Molecular Sciences. 2023;24(16):12816. doi:10.3390/ijms241612816
BibTeX
@article{Lee2023,
author = {Lee, Tak Gyeom and Woo, Seon Min and Seo, Seung Un and Kim, Shin and Park, Jong-Wook and Chang, Young-Chae and Kwon, Taeg Kyu},
title = {Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {16},
pages = {12816},
doi = {10.3390/ijms241612816}
}
EUVIMED